Compound Detail
CHEMBL259850
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL259850 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | YAEMHJKFIIIULI-UHFFFAOYSA-N |
15
Targets
38
Activities
2
Assay Types
2
PK Parameters
20
Publications
0
Known Names
Molecular Properties
308.3
MW (Da)
2.38
ALogP
6
HBA
2
HBD
106.4
PSA (Ų)
0.65
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 28 meas. best 8.68
Ki 10 meas. best 7.6
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Glycogen synthase kinase-3 beta CHEMBL262 | IC50 | 8.68 | 6.9723 | 2.1 | 13 |
| Glycogen synthase kinase-3 beta CHEMBL262 | Ki | 7.6 | 7.194 | 25.1 | 5 |
| Glycogen synthase kinase-3 alpha CHEMBL2850 | Ki | 7.6 | 7.6 | 25.1 | 1 |
| Glycogen synthase kinase-3 beta CHEMBL1075321 | IC50 | 7.0 | 7.0 | 100.0 | 1 |
| Glycogen synthase kinase-3 CHEMBL2095188 | IC50 | 6.98 | 6.98 | 104.0 | 1 |
| Cysteine protease ATG4B CHEMBL1741221 | IC50 | 5.8 | 5.8 | 1600.0 | 1 |
| Cyclin-dependent kinase 2 CHEMBL301 | Ki | 5.3 | 5.3 | 5011.9 | 1 |
| Ribosomal protein S6 kinase beta-1 CHEMBL4501 | Ki | 5.3 | 5.3 | 5011.9 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.23 | 4.905 | 5920.0 | 2 |
| Aurora kinase B CHEMBL2185 | Ki | 5.2 | 5.2 | 6309.6 | 1 |
| Cyclin-dependent kinase 5 CHEMBL4036 | Ki | 5.0 | 5.0 | 10000.0 | 1 |
| BXPC-3 CHEMBL614530 | IC50 | 4.85 | 4.85 | 14000.0 | 1 |
| SUM149PT CHEMBL4296497 | IC50 | 4.82 | 4.82 | 15190.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 4.75 | 4.75 | 17600.0 | 1 |
| HuP-T3 CHEMBL1075477 | IC50 | 4.66 | 4.66 | 22000.0 | 1 |
| MIA PaCa-2 CHEMBL614725 | IC50 | 4.54 | 4.54 | 29000.0 | 1 |
| Glycogen synthase kinase-3 alpha CHEMBL2850 | IC50 | 4.16 | 4.16 | 70000.0 | 1 |
| Cyclin-dependent kinase 5 CHEMBL4036 | IC50 | 4.0 | 4.0 | 100000.0 | 1 |
| Cyclin-dependent kinase 2 CHEMBL301 | IC50 | 4.0 | 4.0 | 100000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 56.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 91.0 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 28342400 | 10.1016/j.ejmech.2017.03.034 | Hep 3B2 | 82 |
| - | 10.6019/CHEMBL3301361 | ADMET | 4 |
| 29208522 | 10.1016/j.bmcl.2017.11.036 | Glycogen synthase kinase-3 beta | 4 |
| 23398362 | 10.1042/bj20121418 | Protein kinase C beta type | 4 |
| 23398362 | 10.1042/bj20121418 | Tyrosine-protein kinase HCK | 4 |
| 23398362 | 10.1042/bj20121418 | cGMP-dependent protein kinase 1 | 4 |
| 23398362 | 10.1042/bj20121418 | Insulin receptor | 4 |
| 23398362 | 10.1042/bj20121418 | Insulin-like growth factor 1 receptor | 4 |
| 23398362 | 10.1042/bj20121418 | Tyrosine-protein kinase Lck | 4 |
| 23398362 | 10.1042/bj20121418 | Cyclin-dependent kinase 5/CDK5 activator 1 | 4 |
| 23398362 | 10.1042/bj20121418 | Serine/threonine-protein kinase mTOR | 4 |
| 21807510 | 10.1016/j.bmcl.2011.06.131 | Glycogen synthase kinase-3 beta | 3 |
| 33991821 | 10.1016/j.bmc.2021.116179 | Glycogen synthase kinase-3 beta | 3 |
| 18077363 | 10.1073/pnas.0708800104 | Glycogen synthase kinase-3 beta | 3 |
| 23398362 | 10.1042/bj20121418 | Tyrosine-protein kinase Fyn | 2 |
| 37573828 | 10.1016/j.ejmech.2023.115718 | Glycogen synthase kinase-3 beta | 2 |
| 23398362 | 10.1042/bj20121418 | Fibroblast growth factor receptor 3 | 2 |
| 23398362 | 10.1042/bj20121418 | Inhibitor of nuclear factor kappa-B kinase subunit alpha | 2 |
| 23398362 | 10.1042/bj20121418 | Ephrin type-A receptor 4 | 2 |
| 23398362 | 10.1042/bj20121418 | Mitogen-activated protein kinase 10 | 2 |
Data from ChEMBL 36 via Core Engine